Skip to main content
. 2025 Sep 12;8:49. doi: 10.20517/cdr.2025.95

Table 3.

Representative resistance-related genes assessed in the current study

Gene Protein name Related drug Mechanism Ref.
ABCB1 ATP-dependent translocase Multiple drugs ↑, drug efflux pump UniProt no. P08183; [14]
ASS1 Argininosuccinate synthase Platinum-based drugs ↓, metabolic reprogramming UniProt no. P00966; [15-17]
ATP7A Copper-transporting ATPase 1 Platinum-based drugs Drug sequestration/efflux UniProt no. Q04656; [18]
dCK Deoxycytidine kinase Pyrimidine antimetabolites Mut, ↓, prevents drug activation UniProt no. P27707; [19]
ECHDC1 Ethylmalonyl-CoA decarboxylase Gemcitabine ↑, altered metabolism UniProt no. Q9NTX5; [20]
hENT1 Equilibrative nucleoside transporter 1 Gemcitabine ↓; reduced drug uptake UniProt no. Q99808; [21]
MT2A Metallothionein-2 Platinum-based drugs ↓; drug inactivation UniProt no. P02795; [22]
SAT1 Diamine acetyltransferase 1 Cisplatin ↓; altered polyamine metabolism UniProt no. P21673; [17]
SLC3A1 Neutral and basic amino acid transport protein Several drugs, incl. cisplatin and doxorubicin ↑, altered nutrient transport UniProt no. Q07837; [23]
TUBβ3 Tubulin βIII Tubulin-interacting agents ↑, mut, altered drug target UniProt no. Q13509; [24]

↑: Upregulated; ↓: downregulated, mut: mutated. ATP: Adenosine triphosphate.